Efficacy and Safety of Pembrolizumab in Non-Small Cell Lung Cancer in Our Institution: A Retrospective Study

被引：0
|
作者：
Saijo, N. [1 ]
Inagaki, Y. [1 ]
Abe, Y. [1 ]
Kono, S. [1 ]
Taniguchi, Y. [1 ]
Otsuka, K. [1 ]
Naoki, Y. [1 ]
Tamiya, A. [1 ]
Okishio, K. [1 ]
Atagi, S. [2 ]
机构：
[1] Natl Hosp Org Kinki Chuo Chest Med Ctr, Internal Med, Sakai, Osaka, Japan
[2] Kinki Chuo Chest Med Ctr, Med Oncol, Sakai, Osaka, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
Pembrolizumab institution retrospective;
D O I：
10.1016/j.jtho.2018.08.1647
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.01-87
引用
收藏
页码：S900 / S900
页数：1
相关论文
共 50 条
  • [31] Pembrolizumab (Pem) for advanced non-small cell lung cancer (aNSCLC): Efficacy and safety in everyday clinical practice.
    Ksienski, Doran
    Wai, Elaine S.
    Croteau, Nicole
    Freeman, Ashley
    Fiorino, Leathia
    Chan, Angela
    Geller, Georgia Samantha
    Poonja, Zia
    Brooks, Edward Geoffrey
    Fenton, Dave
    Irons, Sarah
    Lesperance, Mary
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [32] Efficacy and safety of necitumumab and pembrolizumab combination therapy in patients with stage IV non-small cell lung cancer (NSCLC)
    Besse, B.
    Garrido Lopez, P.
    Puente, J.
    Cortot, A.
    Olmedo Garcia, M. E.
    Perol, M.
    Gil, M.
    Chao, G.
    Shahidi, J.
    Bennouna, J.
    ANNALS OF ONCOLOGY, 2017, 28
  • [33] Advanced non-small cell lung cancer - treatment with Pembrolizumab
    Silvinato, Antonio
    Floriano, Idevaldo
    Bernardo, Wanderley Marques
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 (03): : 256 - 256
  • [34] Advanced non-small cell lung cancer - Treatment with Pembrolizumab
    Silvinato, Antonio
    Floriono, Idevaldo
    Bernardo, Wanderley Marques
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2019, 65 (12): : 1423 - 1432
  • [35] Efficacy and Safety of Necitumumab and Pembrolizumab Combination Therapy in Stage IV Nonsquamous Non-Small Cell Lung Cancer (NSCLC)
    Besse, Benjamin
    Garrido, Pilar
    Puente, Javier
    Cortot, Alexis
    Eugenia Olmedo, Maria
    Perol, Maurice
    Gil, Maciej
    Chao, Grace
    Shahidi, Javad
    Bennouna, Jaafar
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S397 - S397
  • [36] Efficacy and safety of pembrolizumab in the treatment of advanced non-small cell lung cancer: a systematic review and meta-analysis
    Gao, Kaiheng
    Yimin, Nadier
    Song, Binbin
    Pan, Hong
    Lu, Zhouyi
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2025, 17 (01): : 16 - 27
  • [37] Predictors of efficacy of anamorelin in patients with non-small cell lung cancer and cachexia: A retrospective study
    Ishioka, Yoshiko
    Tanaka, Hisashi
    Makiguchi, Tomonori
    Fujishima, Syunsuke
    Nunomura, Yasuhito
    Sakamoto, Hiroaki
    Shiratori, Toshihiro
    Taima, Kageaki
    Tasaka, Sadatomo
    ONCOLOGY LETTERS, 2024, 27 (01)
  • [38] Efficacy of erlotinib and celecoxib for patients with advanced non-small cell lung cancer: A retrospective study
    Jin, Yi-Hua
    Li, Wei-Hong
    Bai, Yan
    Ni, Lei
    MEDICINE, 2019, 98 (10)
  • [39] Association between the efficacy and immune-related adverse events of pembrolizumab and chemotherapy in non-small cell lung cancer patients: a retrospective study
    Kurokawa, Kana
    Mitsuishi, Yoichiro
    Shimada, Naoko
    Kawakami, Yuta
    Miura, Keita
    Miyawaki, Taichi
    Asao, Tetsuhiko
    Ko, Ryo
    Shukuya, Takehito
    Shibayama, Rina
    Nojiri, Shuko
    Takahashi, Kazuhisa
    BMC CANCER, 2022, 22 (01)
  • [40] Association between the efficacy and immune-related adverse events of pembrolizumab and chemotherapy in non-small cell lung cancer patients: a retrospective study
    Kana Kurokawa
    Yoichiro Mitsuishi
    Naoko Shimada
    Yuta Kawakami
    Keita Miura
    Taichi Miyawaki
    Tetsuhiko Asao
    Ryo Ko
    Takehito Shukuya
    Rina Shibayama
    Shuko Nojiri
    Kazuhisa Takahashi
    BMC Cancer, 22
12345